Evidence map›Paper›PMID 27222505›Full record

ArticleDiabetes care2016

Eating Behavior, Low-Frequency Functional Mutations in the Melanocortin-4 Receptor (MC4R) Gene, and Outcomes of Bariatric Operations: A 6-Year Prospective Study.

Amélie Bonnefond, Ramsi Keller, David Meyre, Fanny Stutzmann, Dorothée Thuillier, Dimitre G Stefanov, Philippe Froguel, Fritz F Horber, John G Kral

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05574439 (Young Adults With Early-onset Obesity Treated With Semaglutide -The RESETTLE Study), which is not on this map. Cited by 27 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05574439 phase4completedstarted 2022, after this paper: background citation

Young Adults With Early-onset Obesity Treated With Semaglutide -The RESETTLE Study

Ran2022Enrolled246Registered outcomes54Posted comparisons0ConditionsObesity, AdolescentArmsPlacebo (Semaglutide 3 mg/ml), Semaglutide 3 mg/ml, TCOC treatment
Open the trial in the graph
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 3 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Association of Mutations in theInternational journal of molecular sciences · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Amélie BonnefondCNRS UMR 8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genome Institute for Diabetes, FR 3508, Lille, France Department of Genomics of Common Disease, School of Public Health, Hammersmith Hospital, Imperial College London, London, U.K.
Ramsi KellerDepartment of Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein Dr. Horber Adipositas Stiftung, Zurich, Switzerland.
David MeyreDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Fanny StutzmannCNRS UMR 8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genome Institute for Diabetes, FR 3508, Lille, France.
Dorothée ThuillierCNRS UMR 8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genome Institute for Diabetes, FR 3508, Lille, France.
Dimitre G StefanovScientific Computing Center and Departments of Surgery, Medicine, and Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY.
Philippe FroguelCNRS UMR 8199, Lille Pasteur Institute, Lille, France Lille University, Lille, France European Genome Institute for Diabetes, FR 3508, Lille, France Department of Genomics of Common Disease, School of Public Health, Hammersmith Hospital, Imperial College London, London, U.K. froguel@good.ibl.fr fritz.horber@landesspital.li jkral@downstate.edu.
Fritz F HorberDepartment of Internal Medicine, Landesspital Liechtenstein, Vaduz, Liechtenstein Dr. Horber Adipositas Stiftung, Zurich, Switzerland University of Bern, Bern, Switzerland froguel@good.ibl.fr fritz.horber@landesspital.li jkral@downstate.edu.
John G KralScientific Computing Center and Departments of Surgery, Medicine, and Cell Biology, SUNY Downstate Medical Center, Brooklyn, NY froguel@good.ibl.fr fritz.horber@landesspital.li jkral@downstate.edu.
Institut Pasteur de Lille · FRSUNY Downstate Health Sciences University · USUniversity of Liechtenstein · LICentre National de la Recherche Scientifique · FREuropean Genomic Institute for Diabetes · FRMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveData on the effects of eating behavior and genetics on outcomes of gastrointestinal surgery for diabesity have been sparse, often flawed, and controversial. We aimed to assess long-term outcomes of bariatric operations in patients characterized for eating behavior and rare mutations in the melanocortin-4 receptor (MC4R) gene, which is strongly implicated in energy balance. RESEARCH DESIGN AND

methodsBetween 1996 and 2005, 1,264 severely obese Swiss patients underwent current laparoscopic adjustable gastric banding, gastroduodenal bypass, or a hybrid operation. Of these, 872 patients were followed for a minimum of 6 years and were screened for MC4R mutations. Using regression models, we studied relationships between eating behavior and MC4R mutations and postoperative weight loss, complications, and reoperations after 6 years.

resultsAt baseline, rare functional MC4R mutation carriers exhibited a significantly higher prevalence of binge eating disorder (BED) or loss-of-control eating independent of age, sex, and BMI. Six years after bariatric surgery, the mutation carriers had more major complications than wild-type subjects independent of age, baseline BMI, sex, operation type, and weight loss. Furthermore, high baseline BMI, male sex, BED, and functional MC4R mutations were independent predictors of higher reoperation rates.

conclusionsSequencing of MC4R and eating typology, combined with stratification for sex and baseline BMI, might significantly improve patient allocation to banding or bypass operations for diabesity as well as reduce both complication and reoperation rates.

Indexed as

Feeding BehaviorAdolescentAdultAgedBariatric SurgeryBinge-Eating DisorderBody Mass IndexFemaleFollow-Up StudiesGene Expression RegulationHumansLogistic ModelsMaleMiddle AgedMutationObesityMC4R protein, humanReceptor, Melanocortin, Type 4

Identifiers

PMID27222505
OpenAlexW2398661304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.